Magnetic Nanocrystals Carry Tumor-Killing Drugs

March 7, 2007

Imagine using a focused magnetic field to concentrate anticancer drugs in and around tumors, and then turning off the magnetic field so that the drugs then leave the body. That possiblity may become a reality as a result of work showing that magnetic nanocrystalline iron-nickel alloys can effectively carry and release anticancer agents. The results of these experiments appear in the journal Acta Biomaterialia.

Devesh Misra, Ph.D., and colleagues at the University of Louisiana at Lafayette first prepared magnetic nickel ferrite (NiFe2O4) nanocrystals coated with the biocompatible polymer polymethacrylic acid (PMAA) and developed methods of hooking the anticancer agent doxorubicin to the ends of the PMAA chains.

Characterization experiments showed that the modified nanocrystals retained their strong magnetic properties. The polymer coating prevents the nanocrystals from clumping together, which would degrade their magnetic properties. Moreover, the polymer coating prevents blood proteins from accumulating on the nanocrystals, thereby reducing clearance of the nanocrystals by the immune system.

Drug delivery experiments demonstrated that the nanocrystals slowly and steadily released doxorubicin over 200 hours. However, when the investigators applied a magnetic field to the nanocrystals, drug release rates increased dramatically, with the particles releasing 2.5 times more drug in the first two hours and over the next 24 hours. After 60 hours in a magnetic field, the nanocrystals released approximately 75 percent of their drug payload.

This work is detailed in a paper titled, “On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics.” An abstract of this paper is available through PubMed.

Source: National Cancer Institute

Explore further: Biocompatible photonic crystals expand applications from optics to medicine

Related Stories

Magnetic Nanoworms and Nanocrystals Deliver siRNA to Tumors

September 23, 2009

(PhysOrg.com) -- Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs ...

Creating Highly Sought Magnetic Nanoparticles in One Step

May 2, 2008

Researchers from the University of Minnesota have demonstrated a one-step technique for producing a class of magnetic nanoparticles that could be used in everything from biomedical applications to data storage. Consisting ...

Tiny super magnets could be the future of drug delivery

November 14, 2016

Microscopic crystals could soon be zipping drugs around your body, taking them to diseased organs. In the past, this was thought to be impossible - the crystals, which have special magnetic properties, were so small that ...

Recommended for you

The microscopic origin of efficiency droop in LEDs

November 21, 2017

Light-emitting diodes—or LEDs, as they are commonly known—have been slowly replacing incandescent light bulbs in applications ranging from car taillights to indicators on electronics since their invention in the 1960s.

Borophene shines alone as 2-D plasmonic material

November 20, 2017

An atom-thick film of boron could be the first pure two-dimensional material able to emit visible and near-infrared light by activating its plasmons, according to Rice University scientists.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.